Meet ASC's Distributor Cosmo Bio At The 21st Congress Of The Japanese Society For Regenerative Medicine, Virtual Congress, 3/17-3/19 | ASC

Meet with our distributor at The 21st Congress of the Japanese Society for Regenerative Medicine virtual meeting 3/17-3/19. Learn about how ASC, a leading cell and gene therapy CRO/CDMO, can help support your iPSC research.

Event Details:
When: March 17-19, 2023
Where: Virtual
Event URL: https://www.congre.co.jp/jsrm2022/en/index.html

About Applied StemCell, Inc.

ASC has a Drug Manufacturing License from the California Department of Public Health, Food and Drug Branch (FDB). It has a Quality Management System (ISO 13485 certified) and established cGMP-compliant protocols for cell banking and manufacturing, iPSC generation, genome editing, iPSC differentiation, and cell product manufacturing. With over 13 years of gene-editing and stem cell expertise, ASC offers comprehensive and customized cell and gene CRO/CDMO solutions. Its core iPSC and genome editing (CRISPR and TARGATT^TM) technologies, facilitate site-specific, large cargo (up to 20kb) transgene integration and the development of allogenic cell products.

Media Contact:
Maki Ogawa
Marketing Director, Applied StemCell, Inc.
408-773-8007
maki.ogawa@appliedstemcell.com